Metastasis Prevention – A New Weapon in the Fight Against Cancer
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
Psilocybin in clinical trials for depression, anxiety, and other conditions
Best known for its ability to induce hallucinations, the mushroom-derived compound psilocybin has also been researched for the treatment...
Potential New Targets to Treat Acute Myeloid Leukemia
Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...
Positive Phase 3 trial results for an atopic dermatitis therapy
Atopic dermatitis, often called eczema, affects people of all ages. It is a chronic inflammatory skin condition 1 that...
Cancer vaccines in the clinic and in trials
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
Exon-skipping drug approved for the third subtype of Duchenne muscular dystrophy
Discovering treatments for Duchenne muscular dystrophy has been difficult because the disease is a result of a wide variety...
GLP-1 receptor agonists and/or DPP4 inhibitors: Diabetes drugs may lower the risk of Parkinson’s disease
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
CAR-T Therapy Approved for B-Cell Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma treatment traditionally relied on chemotherapy, radiation, and bone marrow transplant. More recently, immuno-oncology treatments have come to...
Bispecific antibodies are progressing in cancer clinical trials
The human immune system makes antibodies that bind to the same antigen with both of their variable regions, or...
Phase III trial beginning for a Charcot-Marie-Tooth disease therapy
An investigational therapy for Charcot-Marie-Tooth (CMT) disease is beginning its second Phase III trial. The therapy, called PXT3003, is...